| Tumor mechanics and metabolic dysfunction JC Tung, JM Barnes, SR Desai, C Sistrunk, MW Conklin, P Schedin, ... Free Radical Biology and Medicine 79, 269-280, 2015 | 131 | 2015 |
| Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland I Tenvooren, MZ Jenks, H Rashid, KL Cook, JK Muhlemann, C Sistrunk, ... Oncogene 38 (20), 3855-3870, 2019 | 40 | 2019 |
| Environmental exposures during puberty: window of breast cancer risk and epigenetic damage R Natarajan, D Aljaber, D Au, C Thai, A Sanchez, A Nunez, C Resto, ... International journal of environmental research and public health 17 (2), 493, 2020 | 33 | 2020 |
| Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system NC D’Amato, JH Ostrander, ML Bowie, C Sistrunk, A Borowsky, ... Public Library of Science 7 (9), e45684, 2012 | 25 | 2012 |
| Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27Kip1 accumulation C Sistrunk, SH Kim, X Wang, SH Lee, Y Kim, E Macias, ... The American journal of pathology 182 (5), 1854-1864, 2013 | 21 | 2013 |
| Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis X Wang, C Sistrunk, ML Rodriguez-Puebla The American journal of pathology 178 (1), 345-354, 2011 | 19 | 2011 |
| Impact of federal, state, and local housing policies on disparities in cardiovascular disease in Black/African American men and women: from policy to pathways to biology C Sistrunk, N Tolbert, MD Sanchez-Pino, L Erhunmwunsee, N Wright, ... Frontiers in cardiovascular medicine 9, 756734, 2022 | 13 | 2022 |
| Skp2 is necessary for Myc-induced keratinocyte proliferation but dispensable for Myc oncogenic activity in the oral epithelium C Sistrunk, E Macias, K Nakayama, Y Kim, ML Rodriguez-Puebla The American journal of pathology 178 (6), 2470-2477, 2011 | 13 | 2011 |
| Racial disparity in quadruple negative breast cancer: aggressive biology and potential therapeutic targeting and prevention N Jinna, T Jovanovic-Talisman, M LaBarge, R Natarajan, R Kittles, ... Cancers 14 (18), 4484, 2022 | 7 | 2022 |
| Mammographic density: intersection of advocacy, science, and clinical practice K Tossas-Milligan, S Shalabi, V Jones, PJ Keely, MW Conklin, KW Eliceiri, ... Current breast cancer reports 11, 100-110, 2019 | 4 | 2019 |
| Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development X Wang, C Sistrunk, PL Miliani de Marval, Y Kim, ML Rodriguez-Puebla Cell Cycle 11 (2), 335-342, 2012 | 4 | 2012 |
| Epigenetic Dysregulation of KCNK9 Imprinting and Triple-Negative Breast Cancer DA Skaar, EC Dietze, JA Alva-Ornelas, D Ann, DE Schones, T Hyslop, ... Cancers 13 (23), 6031, 2021 | 3 | 2021 |
| Spatiotemporal strategies to identify aggressive biology in precancerous breast biopsies DE Frankhauser, T Jovanovic‐Talisman, L Lai, LD Yee, LV Wang, ... WIREs mechanisms of disease 13 (2), e1506, 2021 | 3 | 2021 |
| Engaging underrepresented adolescents in authentic scientific settings: Scientist role models and improving psychosocial outcomes NR Chávez, A Race, M Bowers, S Kane, C Sistrunk Journal of STEM outreach 2 (1), 2019 | 3 | 2019 |
| Characterization of hair‑follicle side population cells in mouse epidermis and skin tumors SH Kim, C Sistrunk, PL Miliani de Marval, ML Rodriguez‑Puebla Oncology letters 14 (6), 6497-6504, 2017 | 2 | 2017 |
| Challenging the homogeneity of clinical trials to include women of diverse races/ethnicities L Kruper, T Chavez, V Jones, C Vito, S Clancy, A Polverini, C Thai, ... ANNALS OF SURGICAL ONCOLOGY 25, S43-S43, 2018 | 1 | 2018 |
| Influencing women's attitudes toward participation in breast cancer clinical research: Improving inclusion of women of color NR Chavez, A Nunez, AK Wong, TA Chavez, E Rippberger, C Thai, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 29 (6), 2020 | | 2020 |
| Abstract B109: Architecture of increased breast cancer risk K Herold, LD Yee, CM Kalu, LL Kruper, VC Jones, AC Polverini, S Clancy, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), B109-B109, 2020 | | 2020 |
| Abstract B119: Receptiveness of metformin as a breast cancer prevention drug within the Hispanic community M Serrano, A Sanchez, C Thai, K Nerio, C Resto, M Garcia, TA Chavez, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), B119-B119, 2020 | | 2020 |
| Abstract A083: Diversifying breast cancer clinical trial accrual: An approach to recruitment at a Comprehensive Cancer Center TA Chavez, C Thai, A Sanchez, LL Kruper, VC Jones, S Clancy, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), A083-A083, 2020 | | 2020 |
